Notice of special administration instructions for Zemaira. Read more here
For Healthcare Professionals

References

  1. Fregonese L, Stolk J. Hereditary alpha-1-antitrypsin deficiency and its clinical consequences. Orphanet J Rare Dis. 2008;3:16.
  2. de Serres FJ. Alpha-1 antitrypsin deficiency is not a rare disease but a disease that is rarely diagnosed. Environ Health Perspect. 2003;111(16):1851-1854.
  3. Crystal RG. Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy. J Clin Invest. 1990;85(5):1343-1352.
  4. Campos MA, Wanner A, Zhang G, Sandhaus RA. Trends in the diagnosis of symptomatic patients with α-antitrypsin deficiency between 1968 and 2003. Chest. 2005;128(3):1179-1186.
  5. Kelbel T, Morris D, Walker D, Henao MP, Craig T. The allergist’s role in detection of severe alpha-1 antitrypsin deficiency. J Allergy Clin Immunol Pract. 2017. doi:10.1016/j.jaip.2017.01.008.
  6. Sandhaus RA, Turino G, Brantly ML, et al. The diagnosis and management of alpha-1 antitrypsin deficiency in the adult. Chronic Obstr Pulm Dis. 2016;6(3):668-682.
  7. American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med. 2003;168(7):818-900.
  8. Strange C, Stoller JK, Sandhaus RA, Dickson R, Turino G. Results of a survey of patients with alpha-1 antitrypsin deficiency. Respiration. 2006;73(2):185-190.
  9. Siri D, Farah H, Hogarth DK. Distinguishing alpha1-antitrypsin deficiency from asthma. Ann Allergy Asthma Immunol. 2013;111(6):458-464.
  10. Rachelefsky G, Hogarth DK. Issues in the diagnosis of alpha 1-antitrypsin deficiency. J Allergy Clin Immunol. 2008;121(4):833-838.
  11. Alpha-1 Foundation website. What is Alpha-1? http://alpha-1foundation.org/what-is-alpha-1. Accessed January 29, 2018.
  12. Silverman EK, Sandhaus RA. Clinical practice. Alpha1-antitrypsin deficiency. N Engl J Med. 2009;360(26):2749-2757.
  13. Thelin T, Sveger T, McNeil TF. Primary prevention in a high-risk group: smoking habits in adolescents with homozygous alpha-1-antitrypsin deficiency (ATD). Acta Paediatr. 1996;85:1207-1212.
  14. Bernspang E, Sveger T, Piitulainen E. Respiratory symptoms and lung function in 30-year old individuals with alpha-1 antitrypsin deficiency. Respir Med. 2007;101:1971-1976.
  15. Data on file. Available from CSL Behring as DOF ZMR-001.
  16. Stoller JK, Aboussouan LS. A review of α1-antitrypsin deficiency. Am J Respir Crit Care Med. 2012;185(3):246-259.
  17. Petrache I, Hajjar J, Campos M. Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency. Biologics. 2009;3:193-204.
  18. Ferrarotti I, Thun GA, Zorzetto M, et al. Serum levels and genotype distribution of α1-antitrypsin in the general population. Thorax. 2012;67(8):669-774.
  19. Schlade-Bartusiak K, Cox DW. Alpha1-Antitrypsin Deficiency. 2006 Oct 27 [Updated 2008 Feb 6]. In: Pagon RA, Adam MP, Bird TD, et al, eds. GeneReviews™ [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2013.
  20. Stocks JM, Brantly M, Pollock D, et al. Multi-center study: the biochemical efficacy, safety and tolerability of a new α1-proteinase inhibitor, Zemaira. COPD. 2006;3(1):17-23.
  21. Data on file. Available from CSL Behring as DOF ZMR-002.
You are now leaving the current website.